| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 100.06B | 96.04B | 99.25B | 96.97B | 88.66B | 82.47B |
| Gross Profit | 8.66B | 10.90B | 7.53B | 4.71B | 6.59B | 6.60B |
| EBITDA | 4.90B | 6.17B | 3.88B | 763.00M | 2.77B | 3.00B |
| Net Income | 3.42B | 4.35B | 2.73B | 1.16B | 1.70B | 1.79B |
Balance Sheet | ||||||
| Total Assets | 75.35B | 87.64B | 81.42B | 78.61B | 72.38B | 69.92B |
| Cash, Cash Equivalents and Short-Term Investments | 12.86B | 17.00B | 13.46B | 9.29B | 21.50B | 15.90B |
| Total Debt | 3.95B | 0.00 | 3.17B | 5.18B | 209.00M | 229.00M |
| Total Liabilities | 24.21B | 30.61B | 30.80B | 30.99B | 28.21B | 27.03B |
| Stockholders Equity | 51.13B | 57.03B | 50.62B | 47.62B | 44.17B | 42.88B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.45B | 6.99B | -16.83B | 6.61B | -2.66B |
| Operating Cash Flow | 0.00 | 9.22B | 7.62B | -16.19B | 7.18B | -20.00M |
| Investing Cash Flow | 0.00 | -669.00M | -177.00M | -18.00M | -543.00M | -2.34B |
| Financing Cash Flow | 0.00 | -5.06B | -3.07B | 3.80B | -923.00M | -1.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥44.28B | 11.28 | 7.09% | 3.06% | 9.75% | 22.98% | |
77 Outperform | ¥43.41B | 9.32 | ― | 1.96% | 24.91% | 51.00% | |
73 Outperform | ¥40.13B | 8.67 | ― | 3.97% | -3.24% | 60.95% | |
70 Outperform | ¥45.78B | 11.08 | ― | 3.78% | 24.67% | 72.89% | |
67 Neutral | ¥45.98B | 10.16 | ― | 2.19% | 2.18% | 24.71% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥36.47B | 7.55 | ― | 3.88% | 0.72% | 30.10% |